Not Signed In - New Angiogenesis Inhibitor Has Promise For Treating Deadly Brain Tumor
Mon, 22 Jan 2007 12:00 PM EST
... Researchers from the Massachusetts General Hospital (MGH) Cancer Center have found that AZD2171 (RECENTIN(tm)), a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques. [click link for full article] ...
Related Topics
- Brain Tumor
- Benign Tumor
- Benign Tumors
- Cancer
- Brain Cancer
- Pituitary Tumor
- Pituitary Tumors
- Adult Brain Tumors
- Brain Tumor, Adult
- Childhood Brain Tumor
- Childhood Brain Tumors
- Brain Aneurysm
- Brain Tumor, Brain Stem Glioma, Childhood
- Tumor Markers
- Acoustic Neuroma
- Brain Cancer (Brain Tumor)
- Brain Diseases
- Carcinoid Tumors
- Traumatic Brain Injury
- Wilms' Tumor
email this page
print this page
bookmark this page
feedback on this page
